PUBLISHER: IMARC | PRODUCT CODE: 1635964
PUBLISHER: IMARC | PRODUCT CODE: 1635964
Male Hypogonadism Market Report by Therapy Type, Drug Delivery, Application, and Region 2025-2033
The global male hypogonadism market size reached USD 3.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033. A considerable rise in the prevalence of testosterone deficiency in males, the rising awareness of male hypogonadism treatment choices among the patient population, and increasing health consciousness represent some of the key factors driving the market.
Male hypogonadism is a medical condition in which the testes fail to produce enough testosterone, leading to a lack of muscle growth, impaired hair growth, breast development, as well as a lack of deepening of the voice. The medical condition is characterized by a lack of testosterone or spermatozoa production in men. It is caused owing to the disorder related to the testes (primary hypogonadism) or the hypothalamic-pituitary axis (secondary hypogonadism). An individual with hypogonadism may suffer from a variety of organ dysfunctions as well as a reduction in quality of life since it originates from a testicular problem or disorder that affects the hypothalamus and pituitary gland. Hypogonadism in men can be genetic or acquired, caused by hormonal imbalances, medications or aging. Several congenital enzyme abnormalities are responsible for causing different degrees of androgen resistance throughout the body. Hypogonadism is most common in men over the age of 60, and the symptoms and indications of the deficiency vary accordingly.
Male Hypogonadism Market Trends:
The global market is primarily driven by a considerable rise in the prevalence of testosterone deficiency in males, along with the growing infertility rates. This can be attributed to the increasing incidences of chronic lifestyle disorders, including obesity and diabetes. In line with this, the expanding geriatric population that is more susceptible to developing male hypogonadism is also providing an impetus to the market. Moreover, the rising awareness of male hypogonadism treatment choices among the patient population is also acting as a significant growth-inducing factor. Government bodies across several countries are promoting awareness of hypogonadism treatment methods, including testosterone replacement therapy (TST). However, severe adverse reactions associated with external testosterone hormone injections are acting as a significant growth-restraining factor for the male hypogonadism market. Conversely, the increasing number of clinical trials and the emergence of new treatment options are expected to create new male hypogonadism market opportunities for growth during the forecast period. Apart from this, continual technological advancements in the development of medical infrastructure on the global level are creating a positive outlook for the market. Some of the other factors contributing to the market include rapid urbanization, increasing health consciousness, high medical expenditure and extensive research and development (R&D) activities.
Key Market Segmentation:
Therapy Type Insights
Testosterone Replacement Therapy
Gonadotropin-Releasing Hormones Therapy
Drug Delivery Insights
Topical Gels
Injectables
Transdermal Patches
Others
Application Insights
Kallmann Syndrome
Klinefelters Syndrome
Pituitary Disorders
Others
Regional Insights
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for male hypogonadism. Some of the factors driving the North America male hypogonadism market include the growing geriatric population, rising prevalence of sedentary lifestyle and related medical conditions, increasing number of clinical trials, the emergence of new treatment options, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global male hypogonadism market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AbbVie Inc, Endo International Plc, Ferring Holding S.A, Grunenthal GmbH, Lilly USA, LLC (Eli Lilly and Company), Pfizer Inc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd, etc.
Key Questions Answered in This Report:
- How has the global male hypogonadism market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global male hypogonadism market?
- What are the key regional markets?
- Which countries represent the most attractive male hypogonadism markets?
- What is the breakup of the market based on the therapy type?
- What is the breakup of the market based on the drug delivery?
- What is the breakup of the market based on the application?
- What is the competitive structure of the global male hypogonadism market?
- Who are the key players/companies in the global male hypogonadism market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Male Hypogonadism Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Therapy Type
- 6.1 Testosterone Replacement Therapy
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Gonadotropin-Releasing Hormones Therapy
- 6.2.1 Market Trends
- 6.2.3 Market Forecast
7 Market Breakup by Drug Delivery
- 7.1 Topical Gels
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Injectables
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Transdermal Patches
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Application
- 8.1 Kallmann Syndrome
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Klinefelters Syndrome
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Pituitary Disorders
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 AbbVie Inc
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Endo International Plc
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Ferring Holding S.A
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Grunenthal GmbH
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 Lilly USA, LLC (Eli Lilly and Company)
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Pfizer Inc
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Sun Pharmaceutical Industries Limited
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Teva Pharmaceutical Industries Ltd
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.1 AbbVie Inc
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Male Hypogonadism Market: Major Drivers and Challenges
- Figure 2: Global: Male Hypogonadism Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Male Hypogonadism Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Male Hypogonadism Market: Breakup by Therapy Type (in %), 2024
- Figure 5: Global: Male Hypogonadism Market: Breakup by Drug Delivery (in %), 2024
- Figure 6: Global: Male Hypogonadism Market: Breakup by Application (in %), 2024
- Figure 7: Global: Male Hypogonadism Market: Breakup by Region (in %), 2024
- Figure 8: Global: Male Hypogonadism (Testosterone Replacement Therapy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Male Hypogonadism (Testosterone Replacement Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Male Hypogonadism (Gonadotropin-Releasing Hormones Therapy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Male Hypogonadism (Gonadotropin-Releasing Hormones Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Male Hypogonadism (Topical Gels) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Male Hypogonadism (Topical Gels) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Male Hypogonadism (Injectables) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Male Hypogonadism (Injectables) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Male Hypogonadism (Transdermal Patches) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Male Hypogonadism (Transdermal Patches) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Male Hypogonadism (Other Drug Deliveries) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Male Hypogonadism (Other Drug Deliveries) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Male Hypogonadism (Kallmann Syndrome) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Male Hypogonadism (Kallmann Syndrome) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Male Hypogonadism (Klinefelters Syndrome) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Male Hypogonadism (Klinefelters Syndrome) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Male Hypogonadism (Pituitary Disorders) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Male Hypogonadism (Pituitary Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Male Hypogonadism (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Male Hypogonadism (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: North America: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: North America: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: United States: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: United States: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Canada: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Canada: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Asia-Pacific: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Asia-Pacific: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: China: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: China: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Japan: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Japan: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: India: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: India: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: South Korea: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: South Korea: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Australia: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Australia: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Indonesia: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Indonesia: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Others: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Others: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Europe: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Europe: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Germany: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Germany: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: France: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: France: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: United Kingdom: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: United Kingdom: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Italy: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Italy: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Spain: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Spain: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Russia: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Russia: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Others: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Others: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Latin America: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Latin America: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Brazil: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Brazil: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Mexico: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Mexico: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Others: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Others: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Middle East and Africa: Male Hypogonadism Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Middle East and Africa: Male Hypogonadism Market: Breakup by Country (in %), 2024
- Figure 76: Middle East and Africa: Male Hypogonadism Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Global: Male Hypogonadism Industry: Drivers, Restraints, and Opportunities
- Figure 78: Global: Male Hypogonadism Industry: Value Chain Analysis
- Figure 79: Global: Male Hypogonadism Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Male Hypogonadism Market: Key Industry Highlights, 2024 & 2033
- Table 2: Global: Male Hypogonadism Market Forecast: Breakup by Therapy Type (in Million USD), 2025-2033
- Table 3: Global: Male Hypogonadism Market Forecast: Breakup by Drug Delivery (in Million USD), 2025-2033
- Table 4: Global: Male Hypogonadism Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 5: Global: Male Hypogonadism Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Male Hypogonadism Market: Competitive Structure
- Table 7: Global: Male Hypogonadism Market: Key Players
